Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
European equities traded in the US as American depositary receipts were moving higher late Friday morning, up 0.48% to 1,412.34 on the S&P Europe Select ADR Index, which is relatively flat for the week.
From continental Europe, the gainers were led by internet browser company Opera and biopharmaceutical company Genfit , which rose 6.8% and 2.5%, respectively. They were followed by 3D printer company Materialise and biotech firm BioNTech , which were up 2.4% and 1.4%, respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies and biotech firm Evaxion Biotech E, which fell 7.8% and 5.1%, respectively. They were followed by biopharmaceutical company Cellectis and oil and gas company Eni , which were down 1.5% and 1.3%, respectively.
From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo and financial services company Barclays , which increased 2% each. They were followed by financial services company HSBC and cruise line operator Carnival , which were up 1.5% each.
The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics and pharmaceutical company Silence Therapeutics , which dropped 4.1% and 3.7%, respectively. They were followed by biotech firm Autolus Therapeutics and biopharmaceutical company TC Biopharm , which lost 3.1% and 2.8%, respectively.
Opera has an average rating of Buy and mean price target of $27.40, according to analysts polled by FactSet.
Financial stocks were rising in Thursday afternoon trading, with the NYSE Financial Index adding 1% and the Financial Select Sector SPDR Fund (XLF) climbing 1.5%.
The Philadelphia Housing Index was down 0.3%, while the Real Estate Select Sector SPDR Fund (XLRE) was advancing 0.7%.
Bitcoin (BTC/USD) was increasing 0.7% to $84,692, and the yield for 10-year US Treasuries was rising 3.8 basis points to 4.30%.
In economic news, US initial jobless claims rose to 242,000 in the week ended Feb. 22 from an upwardly revised 220,000 in the previous week, beating forecasts for 221,000 in a survey compiled by Bloomberg.
US pending home sales fell by 4.6% in January, below the 0.9% drop expected in a survey compiled by Bloomberg and following a 4.1% decrease in December, according to the National Association of Realtors.
In corporate news, Apollo Global Management is in talks to lead a $35 billion financing package to help Meta develop US-based data centers, Bloomberg reported. Apollo shares rose 1.5%.
Goldman Sachs has eliminated a section titled "diversity and inclusion" from its 2024 annual filing released Thursday. Goldman shares were up 0.3%.
HSBC is cutting around 900 jobs at its digital wealth unit Pinnacle in China, reducing nearly half of its workforce, Reuters reported. HSBC shares added 0.2%.
Most of Europe's top stock indexes close lower, with carmakers among the biggest losers, after President Trump floated 25% tariffs on the European Union. The Stoxx Europe 600 index falls 0.5%, having closed at a record high Wednesday. Italy's FTSE MIB sheds 1.5%, Germany's DAX ends the session 1.1% lower and France's CAC 40 is down 0.5%. Meanwhile, the U.K.'s FTSE 100 gains 0.3%. "European markets looked glum with shares in car makers and luxury goods brands lower, along with tequila maker Diageo," AJ Bell's Danni Hewson says in a market comment. BMW closes 3.8% lower, Porsche is down 3.6% and Mercedes-Benz falls 2.4%. Ferrari plunges 7.9%, hit by news that top shareholder Exor is cutting its stake. (adria.calatayud@wsj.com)
European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.49% to 1,416.32 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet browser company Opera and biopharmaceutical company Grifols , which rose 6% and 5.7% respectively. They were followed by biopharmaceutical company argenx and brewing company Anheuser-Busch InBev , which increased 4.3% and 1.9% respectively.
The decliners from continental Europe were led by electronics conglomerate Philips and 3D printer company Materialise , which lost 2.3% and 2.1% respectively. They were followed by software firm SAP and oil and gas company Eni , which fell 2% and 1.9% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics and Verona Pharma , which climbed 12% and 7% respectively. They were followed by pharmaceutical company Silence Therapeutics and biopharmaceutical company Mereo BioPharma Group , which were up 4.7% and 2.2% respectively.
The decliners from the UK and Ireland were led by communications company WPP and biotech firm Trinity Biotech , which shed 16% and 2.5% respectively. They were followed by utilities company National Grid and alcoholic beverage company Diageo , which dropped 1.6% and 1.2% respectively.
By Chris Wack
Opera shares were trading 7% higher, at $19.70, after the company reported fourth-quarter earnings that beat analysts' expectations.
The Internet technology company said it had quarterly net income of $28.7 million, or 32 cents a share, down from $107.5 million, or $1.20 a share, in the same quarter last year. Analysts polled by FactSet were looking for earnings of $20.5 million, or 23 cents a share.
Revenue for the quarter was $145.8 million, compared with last year's $113 million and the $137.9 million analysts were expecting.
Adjusted earnings were 28 cents a share, compared with the 26 cents a share analysts had forecast.
The company said that for the quarter, it saw higher advertising revenue, and high purchase intent traffic to its advertising partners. Search revenue growth increased 17% over last year.
For the first quarter, Opera said it is expecting revenue of $130 million to $133 million, while analysts are looking for $121.4 million.
Write to Chris Wack at chris.wack@wsj.com
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.